MedCity Influencers

Pandemic-sized Collaboration Transforms the 3 P’s of Healthcare

As we consider the ramifications of the President’s cancellation of the Pandemic emergency, we have time to reflect on the transformation of the 3 P’s of healthcare: People, Policies and Politics.

As we consider the ramifications of the President’s cancellation of the Pandemic emergency, we have time to reflect on the transformation of the 3 P’s of healthcare: People, Policies and Politics. It’s really no longer technology that stops us from advancing healthcare. It’s the 3 P’s. The 3 P’s are what is core to healthcare success and transformation. These 3 P’s have the power to stop us from transforming healthcare and have done so for years, but they also can move healthcare forward in ways we have long hoped.

At the heart of healthcare are the people: the people we care for, those whose jobs are to care for and assist them, and those that support them as family and friends. With every healthcare visit, interaction, and request are policies that address how care is delivered and organizations work together, how families are supported, how we pay for care, and how our institution is differentiated from all others. And finally, we have politics. Politics often defines organizational collaboration and the rules by which we operate and data is integrated, how payments are realized, how research is supported and brought to market, and even what treatments can be utilized.

Out of all that was bad about the Pandemic shone one tiny light. The light of collaboration and persistence; the light of breaking down barriers and getting it done; the light of doing the right thing to help others; the light of innovation; and the light that used to be all of healthcare before the 3 P’s slowed it down.

What we saw during the Pandemic was a breaking down of barriers like we have never seen before. We saw innovation across all industries, organizations and technologies. We saw people leaning in to help each other against unknown odds. We saw people go where they were needed and lend a helping hand regardless of politics or policy. We saw groups come together that had never worked together before or who used to struggle to collaborate. We saw health systems and payers building bridges to each other to support their patients and members. We saw pharma, payers and providers changing how they work together to support families, communities and countries in need. We saw providers traveling and working in areas where there were clinical shortages. We saw creativity in managing supplies and reaching out to neighborhoods. We saw the best in people.

We also saw policies abandoned or quickly modified to meet patient needs. Needed an auth for that? Not anymore. Need a form for that? Don’t worry about it; just get what you need. Certain lab tests are now free. Certain doctor’s visits have no copays. Our hours have been extended. You can get that at more locations. And the list went on. We disrupted what was the old way of managing care.

We saw political rivals become allies. We saw political parties work together against a common foe. We saw government regulations updated, modified and eliminated. New regulations were also put in place to support the needs. Did everyone change? No, but enough was done to make a difference.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

We were able to fundamentally change how healthcare is delivered in the span of a few months.

So what now?

Why does this matter? Because if we could do it then, we can do it now. We can continue to lean in and help each other do the right thing. We can continue to encourage collaboration between teams and organizations. We can break down more barriers. We can build new policies and evolve politics so that we can advance medicine. Instead of holding us back, the transformed 3 P’s have put the care back in healthcare. Let’s not stop now.

Boonyachoat

As Global Vice President of Healthcare and Life Sciences at Coforge, Kelli Bravo helps healthcare and life sciences organizations develop digital transformation and engagement strategies that build relationships, simplify operations, and improve the way healthcare is delivered.

Topics